2719.85 14.65 (0.54%)

25.99% Fall from 52W High

4,886 NSE+BSE Volume

NSE Jul 01, 2022 03:31 PM

Board Meetings - AstraZeneca Pharma India Ltd.

See past and forthcoming board meetings of AstraZeneca Pharma India Ltd. - ASTRAZEN, 506820

Ex-date Purpose Notes
2022-05-26 Audited Results & Final Dividend
2022-02-08 Quarterly Results
2021-11-09 Quarterly Results
2021-08-09 Quarterly Results & Interim Dividend
2021-05-25 Audited Results
2021-02-08 Quarterly Results
2020-11-05 Quarterly Results
2020-08-10 Quarterly Results & Interim Dividend
2020-05-18 Audited Results
2020-02-03 Quarterly Results
2019-11-11 Quarterly Results
2019-08-07 Quarterly Results & Interim Dividend
2019-05-24 Audited Results
2019-02-06 Quarterly Results
2018-11-13 Quarterly Results
2018-08-13 Unaudited Financial Results
2018-05-21 Audited Results
2018-02-05 Quarterly Results
2017-11-06 Quarterly Results
2017-08-08 Quarterly Results
2017-05-09 Audited Results
2017-02-02 Quarterly Results
2016-12-02 Others Mr. Rajesh Marwaha, Chief Financial Officer of the Company hasbeen inducted into the board as Additional and Whole-time Director. His profile is attached.
2016-11-11 Quarterly Results
2016-08-09 Quarterly Results
2016-05-25 Audited Results
2016-02-06 Quarterly Results & Others The Board of Directors approved the re-appointment of Mr. Sanjay Murdeshwar as Managing Director of the Company for a period of 3 years, to be effective from May 02, 2016.
2015-12-02 Others Decided to close the Active Pharmaceutical Ingredient Unit (API Unit) situated at 12th Mile on Bellary Road,Venkatala, Yelahanka, Bangalore - 560063.
2015-11-06 Quarterly Results & Others The Board appointed Ms. Claire-Marie O' Grady as Director of the Company in the vacancy caused by the resignation of Ms. Rebekah Martin with immediate effect.
2015-08-04 Quarterly Results
2015-05-27 Audited Results
2015-02-11 Quarterly Results
2014-11-03 Quarterly Results
2014-08-12 Quarterly Results
2014-05-30 Audited Results
2014-05-05 Others To consider seeking approval of shareholders of the Company through Postal Ballot, for the voluntary delisting proposed by AstraZeneca Pharmaceuticals AB Sweden,Promoter of the company.
2014-04-15 Others To consider for the voluntary delisting proposed by AstraZeneca Pharmaceuticals Promoter of the Company, in terms of Securities and Exchange Board of India, through Postal Ballot.
2014-03-15 Others To consider the voluntary delisting proposal from AstraZeneca Pharmaceuticals AB, Sweden in terms of their letter dated March 01, 2014 at the meeting of the BOD of the Company held on March 15,2014.
2014-03-05 Others
2014-02-10 Quarterly Results
2013-11-11 Quarterly Results
2013-08-13 Quarterly Results
2013-05-21 Audited Results
2013-05-06 Others
2013-05-02 Quarterly Results
2013-02-06 Quarterly Results
2012-11-07 Quarterly Results
2012-08-10 Quarterly Results
2012-05-11 Audited & Quarterly Results
2012-02-02 Quarterly Results
2011-11-10 Quarterly Results
2011-08-08 Quarterly Results
2011-06-14 Others inter alia, to consider and approve the proposal of straightening of land boundaries of factory with IDL Industries Ltd.
2011-05-13 Audited Results & Dividend Fifteen Months.
2011-02-08 Quarterly Results
2010-10-27 Quarterly Results
2010-07-27 Quarterly Results & Others For seeking the consent / approval of the Shareholders of the Company through postal ballot to the delisting proposal initiated by AstraZeneca Pharmaceuticals, AB, Sweden, promoter of the Company.
2010-07-09 Others The Board has deferred the decision on delisting proposal initiated by AstraZeneca Pharmaceuticals AB Sweden, promoter of the Company.
2010-06-29 Voluntary Delisting of Shares To make a voluntary delisting offer to the public Shareholders of the Co. in accordance with the SEBI (DES) Regulations, 2009 with a view to delist the Equity Shares from BSE, NSE & BgSE.
2010-04-27 Others The Board has appointed Ms. Anita Zutshi as the Chief Financial Officer of the Company.
2010-04-26 Quarterly Results
2010-03-25 Others 1. Proposal to augment the Co's Tablet manufacturing plant and facility involving an estimated aggregate outlay of Rs. 70 Crs. 2. Appointment of Mr. Luigi Felice La Corte, as an Additional Director.
2010-02-23 Audited Results, Dividend & Others The Board has approved the change in the accounting year of the Company from "January-December" to "April-March" & Recommended a Dividend of Rs. 10/- per Equity Share of face value of Rs. 2/- each.
2009-10-27 Quarterly Results
2009-07-27 Quarterly Results
2009-04-23 Quarterly Results
2009-02-18 Audited Results & Dividend
2008-10-23 Quarterly Results
2008-07-29 Quarterly Results
2008-04-28 Quarterly Results
2008-02-25 Audited Results & Dividend
2007-10-26 Quarterly Results
2007-07-26 Quarterly Results
2007-04-30 Quarterly Results
2007-03-17 Interim Dividend To consider the approval of the revised Audited Accounts for the financial year ended December 31, 2006, after incorporating necessary changes as to the revocation of recommended dividend & others.
2007-02-23 Accounts & Dividend
2006-10-28 Quarterly Results
2006-09-08 Issue of fully paid bonus debentures Inter alia, to consider a proposal for issue by the Company of secured fully paid bonus debentures from its General Reserve in terms of a Scheme of Arrangement between the Company and its Shareholders
2006-08-28 Issue of fully paid bonus debentures To consider a proposal for issue by the Company of secured fully paid bonus debentures from its General Reserve in terms of a Scheme of Arrangement between the Company and its Shareholders. (deferred)
2006-07-28 Quarterly Results
2006-05-09 Sub Division of Equity shares
2006-04-29 Quarterly Results
2006-02-23 Accounts & Dividend
2005-10-20 Quarterly Results (Revised)
2005-08-24 Accounts
2005-04-27 Quarterly Results
2005-02-16 Accounts & Dividend (Revised)
2004-10-30 Quarterly Results
2004-08-16 Quarterly Results
2004-05-31 Quarterly Results (Revised)
2004-04-21 Others Mr. Bhasker V. Iyer was appinted as an additional Director and Managing Director w.e.f. 06-05-2004.
2004-03-04 Others Astra Pharmaceuticals AB(APAB) a promoter of the company, held 56.50% of the voting share capital of the company in March, 2002.
2004-02-24 Dividend & Accounts
2003-11-26 Quarterly Results
2003-08-26 Quarterly Results
2003-04-28 Quarterly Results
2003-02-27 Dividend, Accounts & Quarterly Results
2002-10-29 Quarterly Results
2002-05-28 Quarterly Results
2002-03-14 Accounts & Dividend (9 months)